Searched for
DEFEND YOUR PORTFOLIO
Jio revs up IPO engine; Accenture shock sinks ITJio Platforms has kicked off its IPO process with the filing of its draft papers with Sebi. This and more in today's ETtech Top 5.- How Musk's tactics left investors clamoring for SpaceX stock and ignoring risksOne investor said that when SpaceX was privately held, he used a connection with a cousin of the billionaire entrepreneur to buy $10 millio...
- The appraisal hangover: How a poor performance review can hurt your career if you react emotionallyCold data, not emotions, will cure your appraisal hangover, says Devashish Chakravarty.
- The rupee warning: Six actions for business leadersThe Indian rupee is dipping to historic lows, approaching the 100-dollar threshold. Driven by market sentiment and a perilous cycle of fore...
- RBI MPC: Iran war puts Malhotra & Co in razor-edge policy bind over inflation, growth and rupeeThe Reserve Bank of India faces a difficult interest-rate decision this week as rising oil prices from the Iran conflict, a record-low rupe...
- Epstein files reveal ongoing ties with this one wealth managerDespite the allegations surrounding Jeffrey Epstein, Bank of America wealth adviser Paul V. Morris maintained connections with Epstein for ...
- The ‘Inevitables’: Warren Buffett's framework for finding companies that will dominate for decadesWarren Buffett divided the investment universe into Inevitables, Highly Probables, and Impostors. The Inevitables are companies whose domin...
- Inherited wealth: How to plan wisely and avoid costly impulsive decisions for long-term financial securityThe primary rule to follow is: do not make rash and immediate decisions. Take time to consider what you have inherited and how to use it in...
- GIFT City vs Dubai vs Singapore: What you need to know while choosing your investment hubIndian wealth is increasingly seeking global anchors, with GIFT City, Dubai's DIFC and Singapore emerging as key contenders. Each hub offer...
- Marico on course to deliver double-digit constant currency growth in international business: Saugata GuptaMarico CEO discusses market share dynamics, rural recovery, deflation impact, and strategy focusing on premium segments. The company target...
- ICC World Cup & Investing: No single strategy will suit all teams and portfolios“In cricket, the top order has to play fearlessly to maximise the field restriction in power-play despite being most prone to the risk of s...
- Defend your portfolio: 5 defence stocks with 'buy' reco have upside potential of up to 42%One sector which has got re-rated due to the policy initiatives by the government has been the defence sector. It is not only PSU companies...
- Here’s how to defend your portfolio from losses in bad timesFMCG, a defensive sector, is resilient during turbulent times, making it an insurance for portfolios. To battle inflation, FMCG companies r...
- Is your portfolio anaemic? Careful, the pharma pill may not help defend against vulnerabilityBrokerages turned cautious on the sector just ahead of September quarter earnings.
- Financial planning lessons from footballBalanced funds create scoring opportunities by investing in equities, even as they cushion the impact of market downturns by investing in d...
- You can win on D-Street by drawing analogy with soccer: Here’s your teamHold these 11 stocks till next FIFA to make above-average returns.
- Debt funds with Jindal Steel & Power securities take a hitICICI Prudential’s fixed maturity plans (FMPs), which held JSPL securities, saw their NAVs dip by up to 3% on Tuesday.
- Lower inflation may give some headroom to RBI to cut rates: IV Subramaniam, Quantum AMCFor the past few months, given the inflation trend, many economists believe that the interest rates may come down but we were still sceptic...
- Hold L&T stock if you want stabiliy in your portfolio: Harendra Kumar, Elara CapitalHarendra Kumar, Managing Director-Institutional Equities, Elara Capital, shares his views on the current outlook of the L&T stock.
- Pharma cos remain a selective pick: Deven ChokseyIn a depreciated currency environment, pharma cos are getting the maximum benefit out of it. So, the pharma companies remain a selective pi...
Load More
